Hasil Pencarian - Sheng-Nan Lo

  • Menampilkan 1 - 4 hasil dari 4
Perbaiki Hasil
  1. 1
    Evaluation of Nanotargeted <sup>111</sup>In-Cyclic RGDfK-Liposome in a Human Melanoma Xenotransplantation Model

    Evaluation of Nanotargeted <sup>111</sup>In-Cyclic RGDfK-Liposome in a Human Melanoma Xenotransplantation Model oleh Si-Yen Liu, Sheng-Nan Lo, Wan-Chi Lee, Wei-Chuan Hsu, Te-Wei Lee, Chih-Hsien Chang

    Diterbitkan 2021-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Berberine Activates Aryl Hydrocarbon Receptor but Suppresses CYP1A1 Induction through miR-21-3p Stimulation in MCF-7 Breast Cancer Cells

    Berberine Activates Aryl Hydrocarbon Receptor but Suppresses CYP1A1 Induction through miR-21-3p Stimulation in MCF-7 Breast Cancer Cells oleh Sheng-Nan Lo, Chun-Wei Wang, Yueh-Shieh Chen, Chiung-Chiao Huang, Tian-Shung Wu, Lih-Ann Li, I-Jung Lee, Yune-Fang Ueng

    Diterbitkan 2017-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Bi-Functional Radiotheranostics of <sup>188</sup>Re-Liposome-Fcy-hEGF for Radio- and Chemo-Therapy of EGFR-Overexpressing Cancer Cells

    Bi-Functional Radiotheranostics of <sup>188</sup>Re-Liposome-Fcy-hEGF for Radio- and Chemo-Therapy of EGFR-Overexpressing Cancer Cells oleh Yi-Shu Huang, Wei-Chuan Hsu, Chien-Hong Lin, Sheng-Nan Lo, Chu-Nian Cheng, Ming-Syuan Lin, Te-Wei Lee, Chih-Hsien Chang, Keng-Li Lan

    Diterbitkan 2021-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Antiinflammation Derived Suzuki-Coupled Fenbufens as COX-2 Inhibitors: Minilibrary Construction and Bioassay

    Antiinflammation Derived Suzuki-Coupled Fenbufens as COX-2 Inhibitors: Minilibrary Construction and Bioassay oleh Shiou-Shiow Farn, Yen-Buo Lai, Kuo-Fong Hua, Hsiang-Ping Chen, Tzu-Yi Yu, Sheng-Nan Lo, Li-Hsin Shen, Rong-Jiun Sheu, Chung-Shan Yu

    Diterbitkan 2022-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: